CRISPR/Cas9-mediated KO of Setdb1 or its interacting partner Atf7ip (activating transcription factor 7-interacting protein) in multiple murine tumor models increased antigen expression and resulted in retardation of tumor growth in immunocompetent mice (Figure 3C). The gene discussed is SETDB1; the disease is neoplasm.